Seoul Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9,949	7,540	6,574	11,728	13,820
Trading Asset Securities	-	-	3,090	-	-
Cash & Short-Term Investments	9,949	7,540	9,664	11,728	13,820
Cash Growth	31.94%	-21.98%	-17.61%	-15.14%	-8.24%
Accounts Receivable	8,470	9,127	5,041	4,925	4,437
Other Receivables	4,046	338.72	89.52	65.46	33.23
Receivables	12,516	9,465	5,131	4,990	4,470
Inventory	11,443	12,104	10,696	9,198	6,466
Prepaid Expenses	27.28	28.18	28.62	28.89	26.42
Other Current Assets	79.55	3,120	90.13	66.38	30.4
Total Current Assets	34,014	32,257	25,609	26,012	24,814
Property, Plant & Equipment	32,124	33,855	31,330	30,676	34,055
Long-Term Investments	3	3	999.4	3	3
Other Intangible Assets	811.9	809.45	841.72	881.35	865.11
Long-Term Deferred Tax Assets	4,232	4,142	4,013	4,386	2,070
Other Long-Term Assets	568.58	552.8	512.48	470.08	443.34
Total Assets	71,754	71,620	63,305	62,428	62,250
Accounts Payable	1,951	2,420	2,831	2,995	1,975
Accrued Expenses	4,839	5,250	4,309	3,933	3,547
Short-Term Debt	5,000	3,000	-	4,000	18,049
Current Portion of Long-Term Debt	-	-	10,000	-	-
Current Portion of Leases	688.32	666.14	485.16	466.11	463.09
Current Income Taxes Payable	-	155.91	-	-	-
Other Current Liabilities	2,421	2,649	2,907	2,497	4,770
Total Current Liabilities	14,898	14,141	20,532	13,891	28,805
Long-Term Debt	10,000	10,000	-	10,000	10,000
Long-Term Leases	1,704	2,460	470.73	481.28	871.11
Pension & Post-Retirement Benefits	2,727	3,697	3,083	2,417	3,396
Other Long-Term Liabilities	1,376	1,149	655.68	216.9	220.46
Total Liabilities	30,705	31,448	24,741	27,006	43,292
Common Stock	5,830	5,830	5,830	5,830	4,262
Additional Paid-In Capital	29,592	29,592	29,592	47,247	33,675
Retained Earnings	5,628	4,750	3,142	-19,414	-20,739
Comprehensive Income & Other	0	0	-	1,760	1,760
Shareholders' Equity	41,050	40,172	38,564	35,422	18,958
Total Liabilities & Equity	71,754	71,620	63,305	62,428	62,250
Total Debt	17,392	16,126	10,956	14,947	29,383
Net Cash (Debt)	-7,443	-8,586	-1,292	-3,219	-15,563
Net Cash Per Share	-	-736.44	-110.83	-358.47	-1825.71
Filing Date Shares Outstanding	-	11.66	11.66	11.66	8.52
Total Common Shares Outstanding	-	11.66	11.66	11.66	8.52
Working Capital	19,116	18,116	5,077	12,121	-3,991
Book Value Per Share	-	3445.48	3307.58	3038.06	2223.90
Tangible Book Value	40,238	39,363	37,722	34,540	18,093
Tangible Book Value Per Share	-	3376.06	3235.39	2962.47	2122.41
Land	5,156	5,156	5,156	5,156	5,156
Buildings	27,916	27,916	27,445	27,334	27,334
Machinery	25,926	25,420	25,747	24,517	23,201
Construction In Progress	332.5	-	40.5	132.85	390.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.